Monday, March 17, 2025 | 03:25 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Abbott plans to launch device that can detect traumatic brain injury

It's designed to collect blood samples and test protein level in blood to assess extent of injury

An Abbott company logo is pictured at the reception of its office in Mumbai
Premium

An Abbott company logo is pictured at the reception of its office in Mumbai

Veena Mani New Delhi
US-headquartered healthcare major Abbott plans to launch a unique device in India that can detect traumatic brain injury using a blood test. 

Sharon Bracken, President for the Point of Care at Abbott, says the company is developing a blood-based biomarker test to run on its portable i-STAT device. 

The pharma giant claims this can identify problems such as concussion, a form of mild traumatic head injury. Currently, the company’s point of care tests include those for haemoglobin and kidney.

Abbott is initiating its trials in the US market this year after which the device will be brought to India. “The device will be

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in